BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Yu L, Ding J, Chen Y. Iron Metabolism in Cancer. Int J Mol Sci. 2018;20:pii: E95. [PMID: 30591630 DOI: 10.3390/ijms20010095] [Cited by in Crossref: 62] [Cited by in F6Publishing: 99] [Article Influence: 15.5] [Reference Citation Analysis]
Number Citing Articles
1 Zheng J, Wang JJ, Ma HM, Shen MQ, Qian ZM, Bao YX. Norcantharidin down-regulates iron contents in the liver and spleen of lipopolysaccharide-treated mice. Redox Rep 2022;27:119-27. [PMID: 35735222 DOI: 10.1080/13510002.2022.2088011] [Reference Citation Analysis]
2 Zhang C, Liu Q, Zhou Y, Hua J, Su R, Ai J, Gu C. HSPA5 Could Be a Prognostic Biomarker Correlated with Immune Infiltration in Breast Cancer. Disease Markers 2022;2022:1-14. [DOI: 10.1155/2022/7177192] [Reference Citation Analysis]
3 Niu R, Zhao F, Dong Z, Li Z, Li S. A stratification system of ferroptosis and iron-metabolism related LncRNAs guides the prediction of the survival of patients with esophageal squamous cell carcinoma. Front Oncol 2022;12:1010074. [DOI: 10.3389/fonc.2022.1010074] [Reference Citation Analysis]
4 Elawdan KA, Farouk S, Aref S, Shoaib H, El-Razik MA, Abbas NH, Younis M, Alshambky AA, Khalil H. Association of vitamin B12/ferritin deficiency in cancer patients with methylomic changes at promotors of TET methylcytosine dioxygenases. Biomark Med 2022. [PMID: 36052661 DOI: 10.2217/bmm-2022-0158] [Reference Citation Analysis]
5 Li C, Wu X, Zheng C, Xu S, Liu Y, Qin J, Fan X, Ye Y, Fei W. Nanotechnology-integrated ferroptosis inducers: a sharp sword against tumor drug resistance. J Mater Chem B 2022. [PMID: 36043505 DOI: 10.1039/d2tb01350a] [Reference Citation Analysis]
6 Baltacı NG, Toraman E, Akyüz M, Kalın ŞN, Budak H. Tip60/Kat5 may be a novel candidate histone acetyltransferase for the regulation of liver iron localization via acetylation. Biometals. [DOI: 10.1007/s10534-022-00435-z] [Reference Citation Analysis]
7 Liu L, Matsumoto M, Matsui-watanabe M, Ochiai K, Callens BKK, Nguyen LC, Kozuki Y, Tanaka M, Nishizawa H, Igarashi K. BACH1 Expression Is Promoted by Tank Binding Kinase 1 (TBK1) in Pancreatic Cancer Cells to Increase Iron and Reduce the Expression of E-Cadherin. Antioxidants 2022;11:1460. [DOI: 10.3390/antiox11081460] [Reference Citation Analysis]
8 Zhang Z, Zhou X, Guo J, Zhang F, Qian Y, Wang G, Duan M, Wang Y, Zhao H, Yang Z, Liu Z, Jiang X. TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment. J Transl Med 2022;20:320. [PMID: 35842634 DOI: 10.1186/s12967-022-03528-y] [Reference Citation Analysis]
9 Wang Q, Chen Y, Gao W, Feng H, Zhang B, Wang H, Lu H, Tan Y, Dong Y, Xu M. Identification and Validation of a Four-Gene Ferroptosis Signature for Predicting Overall Survival of Lung Squamous Cell Carcinoma. Front Oncol 2022;12:933925. [DOI: 10.3389/fonc.2022.933925] [Reference Citation Analysis]
10 Awais M, Aizaz A, Nazneen A, Bhatti QUA, Akhtar M, Wadood A, Atiq Ur Rehman M. A Review on the Recent Advancements on Therapeutic Effects of Ions in the Physiological Environments. Prosthesis 2022;4:263-316. [DOI: 10.3390/prosthesis4020026] [Reference Citation Analysis]
11 Sanati M, Afshari AR, Kesharwani P, Sukhorukov VN, Sahebkar A. Recent trends in the application of nanoparticles in cancer therapy: The involvement of oxidative stress. J Control Release 2022;348:287-304. [PMID: 35644289 DOI: 10.1016/j.jconrel.2022.05.035] [Reference Citation Analysis]
12 Li XF, Fu WF, Zhang J, Song CG. An iron metabolism and immune related gene signature for the prediction of clinical outcome and molecular characteristics of triple-negative breast cancer. BMC Cancer 2022;22:619. [PMID: 35668369 DOI: 10.1186/s12885-022-09679-x] [Reference Citation Analysis]
13 Zhou N, Cui Y, Zhu R, Kuang Y, Ma W, Hou J, Zhu Y, Chen S, Xu X, Tan K, Cao P, Duan X, Fan Y. Deferasirox shows inhibition activity against cervical cancer in vitro and in vivo. Gynecologic Oncology 2022. [DOI: 10.1016/j.ygyno.2022.05.006] [Reference Citation Analysis]
14 Huang S, Le H, Hong G, Chen G, Zhang F, Lu L, Zhang X, Qiu Y, Wang Z, Zhang Q, Ouyang G, Shen J. An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy. Acta Biomaterialia 2022. [DOI: 10.1016/j.actbio.2022.06.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
15 Moon S, Kim M, Kim Y, Lee S. Supplementation with High or Low Iron Reduces Colitis Severity in an AOM/DSS Mouse Model. Nutrients 2022;14:2033. [DOI: 10.3390/nu14102033] [Reference Citation Analysis]
16 Pandrangi SL, Chittineedi P, Chalumuri SS, Meena AS, Neira Mosquera JA, Sánchez Llaguno SN, Pamuru RR, Mohiddin GJ, Mohammad A. Role of Intracellular Iron in Switching Apoptosis to Ferroptosis to Target Therapy-Resistant Cancer Stem Cells. Molecules 2022;27:3011. [DOI: 10.3390/molecules27093011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Sun S, Sun Y, Yang F, Che S, Zhang X, Zhang G, Li Y. Electrochemical synthesis of Ni doped carbon quantum dots for simultaneous fluorometric determination of Fe3+ and Cu2+ ion facilely. Green Chemical Engineering 2022. [DOI: 10.1016/j.gce.2022.05.004] [Reference Citation Analysis]
18 Li Y, Xie M, Jones JB, Zhang Z, Wang Z, Dang T, Wang X, Lipowska M, Mao H. Targeted Delivery of DNA Topoisomerase Inhibitor SN38 to Intracranial Tumors of Glioblastoma Using Sub-5 Ultrafine Iron Oxide Nanoparticles. Adv Healthc Mater 2022;:e2102816. [PMID: 35481625 DOI: 10.1002/adhm.202102816] [Reference Citation Analysis]
19 Zhao J, Wang Y, Tao L, Chen L. Iron Transporters and Ferroptosis in Malignant Brain Tumors. Front Oncol 2022;12:861834. [DOI: 10.3389/fonc.2022.861834] [Reference Citation Analysis]
20 Ni S, Yuan Y, Kuang Y, Li X. Iron Metabolism and Immune Regulation. Front Immunol 2022;13:816282. [PMID: 35401569 DOI: 10.3389/fimmu.2022.816282] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
21 Chung KW, Cho YE, Kim SJ, Hwang S. Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitis. Arch Pharm Res 2022. [PMID: 35391713 DOI: 10.1007/s12272-022-01379-1] [Reference Citation Analysis]
22 Liu Y, Tan S, Wu Y, Tan S. The Emerging Role of Ferroptosis in Sepsis. DNA Cell Biol 2022. [PMID: 35353620 DOI: 10.1089/dna.2021.1072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Tarhan D, Özsobaci NP, Ergün DD, Ercan AM. Investigation of extracellular medium osmolality depending on zinc application and incubation time on A549 cancer cells. J Biol Phys 2022. [PMID: 35325363 DOI: 10.1007/s10867-022-09604-0] [Reference Citation Analysis]
24 Song X, Xin S, Zhang Y, Mao J, Duan C, Cui K, Chen L, Li F, Liu Z, Wang T, Liu J, Liu X, Song W. Identification and Quantification of Iron Metabolism Landscape on Therapy and Prognosis in Bladder Cancer. Front Cell Dev Biol 2022;10:810272. [PMID: 35265613 DOI: 10.3389/fcell.2022.810272] [Reference Citation Analysis]
25 Huang N, Wei Y, Cheng Y, Wang X, Wang Q, Chen D, Li W. Iron metabolism protein transferrin receptor 1 involves in cervical cancer progression by affecting gene expression and alternative splicing in HeLa cells. Genes Genom. [DOI: 10.1007/s13258-021-01205-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Loh D, Reiter RJ. Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance. Molecules 2022;27:705. [PMID: 35163973 DOI: 10.3390/molecules27030705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
27 Liu H, Liu L, Liu Q, He F, Zhu H. LncRNA HOXD-AS1 affects proliferation and apoptosis of cervical cancer cells by promoting FRRS1 expression via transcription factor ELF1. Cell Cycle 2022;:1-11. [PMID: 34985386 DOI: 10.1080/15384101.2021.2020962] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
28 Sang Y, Deng Q, Cao F, Liu Z, You Y, Liu H, Ren J, Qu X. Remodeling Macrophages by an Iron Nanotrap for Tumor Growth Suppression. ACS Nano 2021;15:19298-309. [PMID: 34783526 DOI: 10.1021/acsnano.1c05392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Szymonik J, Wala K, Górnicki T, Saczko J, Pencakowski B, Kulbacka J. The Impact of Iron Chelators on the Biology of Cancer Stem Cells. Int J Mol Sci 2021;23:89. [PMID: 35008527 DOI: 10.3390/ijms23010089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
30 Sp N, Kang DY, Jo ES, Lee JM, Bae SW, Jang KJ. Pivotal Role of Iron Homeostasis in the Induction of Mitochondrial Apoptosis by 6-Gingerol Through PTEN Regulated PD-L1 Expression in Embryonic Cancer Cells. Front Oncol 2021;11:781720. [PMID: 34804985 DOI: 10.3389/fonc.2021.781720] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Hua X, Duan F, Huang J, Bi X, Xia W, Song C, Wang L, Jiang C, Yuan Z. A Novel Prognostic Model Based on the Serum Iron Level for Patients With Early-Stage Triple-Negative Breast Cancer. Front Cell Dev Biol 2021;9:777215. [PMID: 34805180 DOI: 10.3389/fcell.2021.777215] [Reference Citation Analysis]
32 Logie E, Van Puyvelde B, Cuypers B, Schepers A, Berghmans H, Verdonck J, Laukens K, Godderis L, Dhaenens M, Deforce D, Vanden Berghe W. Ferroptosis Induction in Multiple Myeloma Cells Triggers DNA Methylation and Histone Modification Changes Associated with Cellular Senescence. Int J Mol Sci 2021;22:12234. [PMID: 34830117 DOI: 10.3390/ijms222212234] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
33 Park JM, Mau CZ, Chen YC, Su YH, Chen HA, Huang SY, Chang JS, Chiu CF. A case-control study in Taiwanese cohort and meta-analysis of serum ferritin in pancreatic cancer. Sci Rep 2021;11:21242. [PMID: 34711879 DOI: 10.1038/s41598-021-00650-7] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
34 Sp N, Kang DY, Jo ES, Lee JM, Jang KJ. Iron Metabolism as a Potential Mechanism for Inducing TRAIL-Mediated Extrinsic Apoptosis Using Methylsulfonylmethane in Embryonic Cancer Stem Cells. Cells 2021;10:2847. [PMID: 34831070 DOI: 10.3390/cells10112847] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
35 Rishi G, Huang G, Subramaniam VN. Cancer: The role of iron and ferroptosis. Int J Biochem Cell Biol 2021;141:106094. [PMID: 34628027 DOI: 10.1016/j.biocel.2021.106094] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
36 Joshi P, Basso B, Wang H, Hong SH, Giardina C, Shin DG. rPAC: Route based pathway analysis for cohorts of gene expression data sets. Methods 2021:S1046-2023(21)00227-9. [PMID: 34628030 DOI: 10.1016/j.ymeth.2021.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
37 Wijesinghe TP, Dharmasivam M, Dai CC, Richardson DR. Innovative therapies for neuroblastoma: The surprisingly potent role of iron chelation in up-regulating metastasis and tumor suppressors and down-regulating the key oncogene, N-myc. Pharmacol Res 2021;173:105889. [PMID: 34536548 DOI: 10.1016/j.phrs.2021.105889] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
38 Argenziano M, Tortora C, Pota E, Di Paola A, Di Martino M, Di Leva C, Di Pinto D, Rossi F. Osteosarcoma in Children: Not Only Chemotherapy. Pharmaceuticals (Basel) 2021;14:923. [PMID: 34577623 DOI: 10.3390/ph14090923] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
39 Chen F, Fan Y, Hou J, Liu B, Zhang B, Shang Y, Chang Y, Cao P, Tan K. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer. Aging (Albany NY) 2021;13:21671-99. [PMID: 34518441 DOI: 10.18632/aging.203512] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
40 Yan Y, Cai J, Huang Z, Cao X, Tang P, Wang Z, Zhang F, Xia S, Shen B. A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer. Front Cell Dev Biol 2021;9:712230. [PMID: 34490263 DOI: 10.3389/fcell.2021.712230] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
41 Chen F, Han B, Meng Y, Han Y, Liu B, Zhang B, Chang Y, Cao P, Fan Y, Tan K. Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer. Aging (Albany NY) 2021;13:20438-67. [PMID: 34413268 DOI: 10.18632/aging.203427] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
42 Yang YW, Dai CM, Chen XH, Feng JF. The Relationship between Serum Trace Elements and Oxidative Stress of Patients with Different Types of Cancer. Oxid Med Cell Longev 2021;2021:4846951. [PMID: 34349873 DOI: 10.1155/2021/4846951] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
43 Hui Y, Tang T, Wang J, Zhao H, Yang HY, Xi J, Zhang B, Fang J, Gao K, Wu Y. Fusaricide is a Novel Iron Chelator that Induces Apoptosis through Activating Caspase-3. J Nat Prod 2021;84:2094-103. [PMID: 34292737 DOI: 10.1021/acs.jnatprod.0c01322] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Yao F, Cui X, Zhang Y, Bei Z, Wang H, Zhao D, Wang H, Yang Y. Iron regulatory protein 1 promotes ferroptosis by sustaining cellular iron homeostasis in melanoma. Oncol Lett 2021;22:657. [PMID: 34386079 DOI: 10.3892/ol.2021.12918] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
45 Marzo T, La Mendola D. The Effects on Angiogenesis of Relevant Inorganic Chemotherapeutics. Curr Top Med Chem 2021;21:73-86. [PMID: 33243124 DOI: 10.2174/1568026620666201126163436] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
46 Lu L, Liu LP, Zhao QQ, Gui R, Zhao QY. Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma. Front Oncol 2021;11:675545. [PMID: 34249715 DOI: 10.3389/fonc.2021.675545] [Cited by in F6Publishing: 21] [Reference Citation Analysis]
47 Zhang M, Acklin S, Gillenwater J, Du W, Patra M, Yu H, Xu B, Yu J, Xia F. SIRT2 promotes murine melanoma progression through natural killer cell inhibition. Sci Rep 2021;11:12988. [PMID: 34155309 DOI: 10.1038/s41598-021-92445-z] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
48 Jin J, Liu C, Yu S, Cai L, Sitrakiniaina A, Gu R, Li W, Wu F, Xue X. A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma. Aging (Albany NY) 2021;13:16144-64. [PMID: 34115610 DOI: 10.18632/aging.203140] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
49 Lu Y, Ruan G, Du W, Li J, Yang N, Wu Q, Lu L, Zhang C, Li L. Recent progress in rational design of fluorescent probes for Fe2+ and bioapplication. Dyes and Pigments 2021;190:109337. [DOI: 10.1016/j.dyepig.2021.109337] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
50 Mantilla-Escalante DC, López de Las Hazas MC, Crespo MC, Martín-Hernández R, Tomé-Carneiro J, Del Pozo-Acebo L, Salas-Salvadó J, Bulló M, Dávalos A. Mediterranean diet enriched in extra-virgin olive oil or nuts modulates circulating exosomal non-coding RNAs. Eur J Nutr 2021. [PMID: 34027583 DOI: 10.1007/s00394-021-02594-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
51 Ronco AL, Martínez-López W, Calderón JM, Golomar W. Dietary acid load and lung cancer risk: A case-control study in men. Cancer Treat Res Commun 2021;28:100382. [PMID: 33957561 DOI: 10.1016/j.ctarc.2021.100382] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
52 Imanaka S, Yamada Y, Kawahara N, Kobayashi H. A delicate redox balance between iron and heme oxygenase-1 as an essential biological feature of endometriosis. Arch Med Res 2021;52:641-7. [PMID: 33863580 DOI: 10.1016/j.arcmed.2021.03.006] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
53 Fan Y, Liu B, Chen F, Song Z, Han B, Meng Y, Hou J, Cao P, Chang Y, Tan K. Hepcidin Upregulation in Lung Cancer: A Potential Therapeutic Target Associated With Immune Infiltration. Front Immunol 2021;12:612144. [PMID: 33868231 DOI: 10.3389/fimmu.2021.612144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
54 Shi Z, Zhang L, Zheng J, Sun H, Shao C. Ferroptosis: Biochemistry and Biology in Cancers. Front Oncol 2021;11:579286. [PMID: 33868986 DOI: 10.3389/fonc.2021.579286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
55 Xiong H, Wang C, Wang Z, Lu H, Yao J. Self-assembled nano-activator constructed ferroptosis-immunotherapy through hijacking endogenous iron to intracellular positive feedback loop. Journal of Controlled Release 2021;332:539-52. [DOI: 10.1016/j.jconrel.2021.03.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
56 Aksan A, Farrag K, Aksan S, Schroeder O, Stein J. Flipside of the Coin: Iron Deficiency and Colorectal Cancer. Front Immunol 2021;12:635899. [PMID: 33777027 DOI: 10.3389/fimmu.2021.635899] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
57 Liu B, Song Z, Fan Y, Zhang G, Cao P, Li D, Liu X, Chang Y, Tan K. Downregulation of FPN1 acts as a prognostic biomarker associated with immune infiltration in lung cancer. Aging (Albany NY) 2021;13:8737-61. [PMID: 33714956 DOI: 10.18632/aging.202685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
58 Yang Y, Tian Q, Wu S, Li Y, Yang K, Yan Y, Shang L, Li A, Zhang L. Blue light-triggered Fe2+-release from monodispersed ferrihydrite nanoparticles for cancer iron therapy. Biomaterials 2021;271:120739. [PMID: 33690102 DOI: 10.1016/j.biomaterials.2021.120739] [Cited by in Crossref: 1] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
59 Tariba Lovaković B, Živković Semren T, Safner T, Gamulin M, Soče M, Pizent A. Is low-level metal exposure related to testicular cancer? Journal of Environmental Science and Health, Part C 2021;39:87-107. [DOI: 10.1080/26896583.2021.1874234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Mischkulnig M, Kiesel B, Lötsch D, Roetzer T, Borkovec M, Wadiura LI, Roessler K, Hervey-Jumper S, Penninger JM, Berger MS, Widhalm G, Erhart F. Heme Biosynthesis mRNA Expression Signature: Towards a Novel Prognostic Biomarker in Patients with Diffusely Infiltrating Gliomas. Cancers (Basel) 2021;13:662. [PMID: 33562253 DOI: 10.3390/cancers13040662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
61 Zhang Y, Kong Y, Ma Y, Ni S, Wikerholmen T, Xi K, Zhao F, Zhao Z, Wang J, Huang B, Chen A, Yao Z, Han M, Feng Z, Hu Y, Thorsen F, Wang J, Li X. Loss of COPZ1 induces NCOA4 mediated autophagy and ferroptosis in glioblastoma cell lines. Oncogene 2021;40:1425-39. [PMID: 33420375 DOI: 10.1038/s41388-020-01622-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
62 Menghini S, Ho PS, Gwisai T, Schuerle S. Magnetospirillum magneticum as a Living Iron Chelator Induces TfR1 Upregulation and Decreases Cell Viability in Cancer Cells. Int J Mol Sci 2021;22:E498. [PMID: 33419059 DOI: 10.3390/ijms22020498] [Reference Citation Analysis]
63 Summers KL, Dolgova NV, Gagnon KB, Sopasis GJ, James AK, Lai B, Sylvain NJ, Harris HH, Nichol HK, George GN, Pickering IJ. PBT2 acts through a different mechanism of action than other 8-hydroxyquinolines: an X-ray fluorescence imaging study. Metallomics 2020;12:1979-94. [PMID: 33169753 DOI: 10.1039/d0mt00222d] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
64 Mehta KJ, Sharp PA. Iron elevates mesenchymal and metastatic biomarkers in HepG2 cells. Sci Rep 2020;10:21926. [PMID: 33318518 DOI: 10.1038/s41598-020-78348-5] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
65 Haferkamp S, Drexler K, Federlin M, Schlitt HJ, Berneburg M, Adamski J, Gaumann A, Geissler EK, Ganapathy V, Parkinson EK, Mycielska ME. Extracellular Citrate Fuels Cancer Cell Metabolism and Growth. Front Cell Dev Biol 2020;8:602476. [PMID: 33425906 DOI: 10.3389/fcell.2020.602476] [Cited by in Crossref: 4] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
66 Pu F, Chen F, Zhang Z, Shi D, Zhong B, Lv X, Tucker AB, Fan J, Li AJ, Qin K, Hu D, Chen C, Wang H, He F, Ni N, Huang L, Liu Q, Wagstaff W, Luu HH, Haydon RC, Shen L, He T, Liu J, Shao Z. Ferroptosis as a novel form of regulated cell death: Implications in the pathogenesis, oncometabolism and treatment of human cancer. Genes & Diseases 2020. [DOI: 10.1016/j.gendis.2020.11.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
67 Lelièvre P, Sancey L, Coll JL, Deniaud A, Busser B. Iron Dysregulation in Human Cancer: Altered Metabolism, Biomarkers for Diagnosis, Prognosis, Monitoring and Rationale for Therapy. Cancers (Basel) 2020;12:E3524. [PMID: 33255972 DOI: 10.3390/cancers12123524] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
68 Zhou D, Zhang Y, Mamtawla G, Wan S, Gao X, Zhang L, Li G, Wang X. Iron overload is related to muscle wasting in patients with cachexia of gastric cancer: using quantitative proteome analysis. Med Oncol 2020;37:113. [PMID: 33196891 DOI: 10.1007/s12032-020-01439-w] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
69 Piatek M, Griffith DM, Kavanagh K. Quantitative proteomic reveals gallium maltolate induces an iron-limited stress response and reduced quorum-sensing in Pseudomonas aeruginosa. J Biol Inorg Chem 2020;25:1153-65. [DOI: 10.1007/s00775-020-01831-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
70 Tang B, Zhu J, Li J, Fan K, Gao Y, Cheng S, Kong C, Zheng L, Wu F, Weng Q, Lu C, Ji J. The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma. Cell Commun Signal 2020;18:174. [PMID: 33115468 DOI: 10.1186/s12964-020-00663-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 60] [Article Influence: 9.5] [Reference Citation Analysis]
71 Shibabaw T, Teferi B, Molla MD, Ayelign B. Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer. Breast Cancer (Dove Med Press) 2020;12:165-80. [PMID: 33116818 DOI: 10.2147/BCTT.S276404] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
72 Mancinelli R, Cutone A, Rosa L, Lepanto MS, Onori P, Pannarale L, Franchitto A, Gaudio E, Valenti P. Different iron-handling in inflamed small and large cholangiocytes and in small and large-duct type intrahepatic cholangiocarcinoma. Eur J Histochem 2020;64. [PMID: 33131269 DOI: 10.4081/ejh.2020.3156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Jiang X, Zhou T, Bai R, Xie Y. Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities. J Med Chem 2020;63:14470-501. [PMID: 33023291 DOI: 10.1021/acs.jmedchem.0c01480] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
74 Krzywoszyńska K, Witkowska D, Swiatek-Kozlowska J, Szebesczyk A, Kozłowski H. General Aspects of Metal Ions as Signaling Agents in Health and Disease. Biomolecules 2020;10:E1417. [PMID: 33036384 DOI: 10.3390/biom10101417] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
75 Zhou Y, Que KT, Tang HM, Zhang P, Fu QM, Liu ZJ. Anti-CD206 antibody-conjugated Fe3O4-based PLGA nanoparticles selectively promote tumor-associated macrophages to polarize to the pro-inflammatory subtype. Oncol Lett 2020;20:298. [PMID: 33101492 DOI: 10.3892/ol.2020.12161] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
76 Li Y, Jin C, Shen M, Wang Z, Tan S, Chen A, Wang S, Shao J, Zhang F, Zhang Z, Zheng S. Iron regulatory protein 2 is required for artemether -mediated anti-hepatic fibrosis through ferroptosis pathway. Free Radic Biol Med 2020;160:845-59. [PMID: 32947011 DOI: 10.1016/j.freeradbiomed.2020.09.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
77 Li Y, Shen M, Jin C, Gao L, Liang B, Wang Z, Tan S, Chen A, Zhang F, Zhang Z, Zheng S. Regulation of ferroptosis by ncRNA : A new direction. IUBMB Life 2020;72:2290-302. [DOI: 10.1002/iub.2381] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Elgendy SM, Alyammahi SK, Alhamad DW, Abdin SM, Omar HA. Ferroptosis: An emerging approach for targeting cancer stem cells and drug resistance. Crit Rev Oncol Hematol 2020;155:103095. [PMID: 32927333 DOI: 10.1016/j.critrevonc.2020.103095] [Cited by in Crossref: 8] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
79 Ji Y, Yin Y, Zhang W. Integrated Bioinformatic Analysis Identifies Networks and Promising Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma. Int J Genomics 2020;2020:2061024. [PMID: 32775402 DOI: 10.1155/2020/2061024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
80 Scricciolo A, Elli L, Doneda L, Bascunan KA, Branchi F, Ferretti F, Vecchi M, Roncoroni L. Efficacy of a High-Iron Dietary Intervention in Women with Celiac Disease and Iron Deficiency without Anemia: A Clinical Trial. Nutrients 2020;12:E2122. [PMID: 32708973 DOI: 10.3390/nu12072122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
81 Rusu IG, Suharoschi R, Vodnar DC, Pop CR, Socaci SA, Vulturar R, Istrati M, Moroșan I, Fărcaș AC, Kerezsi AD, Mureșan CI, Pop OL. Iron Supplementation Influence on the Gut Microbiota and Probiotic Intake Effect in Iron Deficiency-A Literature-Based Review. Nutrients 2020;12:E1993. [PMID: 32635533 DOI: 10.3390/nu12071993] [Cited by in Crossref: 18] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
82 Hu Z, Mi Y, Qian H, Guo N, Yan A, Zhang Y, Gao X. A Potential Mechanism of Temozolomide Resistance in Glioma-Ferroptosis. Front Oncol 2020;10:897. [PMID: 32656078 DOI: 10.3389/fonc.2020.00897] [Cited by in Crossref: 7] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
83 Fiorillo M, Tóth F, Brindisi M, Sotgia F, Lisanti MP. Deferiprone (DFP) Targets Cancer Stem Cell (CSC) Propagation by Inhibiting Mitochondrial Metabolism and Inducing ROS Production. Cells 2020;9:E1529. [PMID: 32585919 DOI: 10.3390/cells9061529] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
84 Kontoghiorghes GJ, Kontoghiorghe CN. Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases. Cells 2020;9:E1456. [PMID: 32545424 DOI: 10.3390/cells9061456] [Cited by in Crossref: 15] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
85 Muhammad JS, Bajbouj K, Shafarin J, Hamad M. Estrogen-induced epigenetic silencing of FTH1 and TFRC genes reduces liver cancer cell growth and survival. Epigenetics 2020;15:1302-18. [PMID: 32476555 DOI: 10.1080/15592294.2020.1770917] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
86 Xu Y, Qin Z, Ma J, Cao W, Zhang P. Recent progress in nanotechnology based ferroptotic therapies for clinical applications. Eur J Pharmacol 2020;880:173198. [PMID: 32473167 DOI: 10.1016/j.ejphar.2020.173198] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
87 Serra M, Columbano A, Ammarah U, Mazzone M, Menga A. Understanding Metal Dynamics Between Cancer Cells and Macrophages: Competition or Synergism? Front Oncol 2020;10:646. [PMID: 32426284 DOI: 10.3389/fonc.2020.00646] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
88 Chen MY, Juengpanich S, Hu JH, Topatana W, Cao JS, Tong CH, Lin J, Cai XJ. Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma. World J Gastroenterol 2020; 26(10): 1042-1055 [PMID: 32205995 DOI: 10.3748/wjg.v26.i10.1042] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Schnetz M, Meier JK, Rehwald C, Mertens C, Urbschat A, Tomat E, Akam EA, Baer P, Roos FC, Brüne B, Jung M. The Disturbed Iron Phenotype of Tumor Cells and Macrophages in Renal Cell Carcinoma Influences Tumor Growth. Cancers (Basel) 2020;12:E530. [PMID: 32106629 DOI: 10.3390/cancers12030530] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
90 Jaganjac M, Borovic Sunjic S, Zarkovic N. Utilizing Iron for Targeted Lipid Peroxidation as Anticancer Option of Integrative Biomedicine: A Short Review of Nanosystems Containing Iron. Antioxidants (Basel) 2020;9:E191. [PMID: 32106528 DOI: 10.3390/antiox9030191] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
91 Kopylov AT, Stepanov AA, Malsagova KA, Soni D, Kushlinsky NE, Enikeev DV, Potoldykova NV, Lisitsa AV, Kaysheva AL. Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development. Molecules 2020;25:E619. [PMID: 32023884 DOI: 10.3390/molecules25030619] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
92 Canesin G, Hejazi SM, Swanson KD, Wegiel B. Heme-Derived Metabolic Signals Dictate Immune Responses. Front Immunol 2020;11:66. [PMID: 32082323 DOI: 10.3389/fimmu.2020.00066] [Cited by in Crossref: 20] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
93 Wei Y, Lv H, Shaikh AB, Han W, Hou H, Zhang Z, Wang S, Shang P. Directly targeting glutathione peroxidase 4 may be more effective than disrupting glutathione on ferroptosis-based cancer therapy. Biochim Biophys Acta Gen Subj 2020;1864:129539. [PMID: 31958545 DOI: 10.1016/j.bbagen.2020.129539] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
94 Fiorito V, Chiabrando D, Petrillo S, Bertino F, Tolosano E. The Multifaceted Role of Heme in Cancer. Front Oncol 2019;9:1540. [PMID: 32010627 DOI: 10.3389/fonc.2019.01540] [Cited by in Crossref: 29] [Cited by in F6Publishing: 41] [Article Influence: 14.5] [Reference Citation Analysis]
95 Xuan W, Xia Y, Li T, Wang L, Liu Y, Tan W. Molecular Self-Assembly of Bioorthogonal Aptamer-Prodrug Conjugate Micelles for Hydrogen Peroxide and pH-Independent Cancer Chemodynamic Therapy. J Am Chem Soc 2020;142:937-44. [PMID: 31858794 DOI: 10.1021/jacs.9b10755] [Cited by in Crossref: 54] [Cited by in F6Publishing: 98] [Article Influence: 18.0] [Reference Citation Analysis]
96 Bae DH, Gholam Azad M, Kalinowski DS, Lane DJR, Jansson PJ, Richardson DR. Ascorbate and Tumor Cell Iron Metabolism: The Evolving Story and Its Link to Pathology. Antioxid Redox Signal 2020;33:816-38. [PMID: 31672021 DOI: 10.1089/ars.2019.7903] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
97 Greenshields AL, Power Coombs MR, Fernando W, Holbein BE, Hoskin DW. DIBI, a novel 3-hydroxypyridin-4-one chelator iron-binding polymer, inhibits breast cancer cell growth and functions as a chemosensitizer by promoting S-phase DNA damage. Biometals 2019;32:909-21. [PMID: 31624972 DOI: 10.1007/s10534-019-00222-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
98 Petronek MS, Spitz DR, Buettner GR, Allen BG. Linking Cancer Metabolic Dysfunction and Genetic Instability through the Lens of Iron Metabolism. Cancers (Basel) 2019;11:E1077. [PMID: 31366108 DOI: 10.3390/cancers11081077] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
99 Zhang S, Chang W, Wu H, Wang Y, Gong Y, Zhao Y, Liu S, Wang H, Svatek RS, Rodriguez R, Wang Z. Pan‐cancer analysis of iron metabolic landscape across the Cancer Genome Atlas. J Cell Physiol 2020;235:1013-24. [DOI: 10.1002/jcp.29017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]